Cataract and mortality. The Beijing eye study

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 246, Issue 4, 2008, Pages 615-617

  Xu, Liang ^a   Cui, Tong Tong ^a   Wang, Ya Xing ^a   Jonas, Jost B ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Beijing eye study; Cataract; Mortality

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CATARACT; CHINA; COMMUNITY CARE; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; SUBCAPSULAR CATARACT; VISUAL IMPAIRMENT;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CATARACT; CAUSE OF DEATH; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 41349084772     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-007-0731-1     Document Type: Article

References (15)

1. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY (1995) Global data on blindness. Bull World Health Organ 73:115-121
2. Wang JJ, Mitchell P, Simpson JM, Cumming RG, Smith W (2001) Visual impairment, age-related cataract, and mortality. Arch Ophthalmol 119:1186-1190
3. Clemons TE, Kurini N, Sperduto RD, AREDS Research Group (2004) Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Arch Ophthalmol 122:716-726
4. Klein BE, Klein R (2006) Age-related eye disease, visual impairment, and survival: The Beaver Dam Eye Study. Arch Ophthalmol 124:243-249
5. Cugati S, Cumming RG, Smith W, Burlutsky G, Mitchell P, Wang JJ (2007) Visual impairment, age-related macular degeneration, cataract, and long-term mortality: The Blue Mountains Eye Study. Arch Ophthalmol 125:917-924
6. Xu L, Cui T, Sun B, Zheng Y, Hu A, Li J, Ma K, Jonas JB (2006) Prevalence and risk factors of lens opacities in urban and rural Chinese in Beijing. Ophthalmology 113:747-755
7. McCarty CA, Nanjan MB, Taylor HR (2001) Vision impairment predicts 5 year mortality. Br J Ophthalmol 85:322-326
8. Thiagarajan M, Evans JR, Smeeth L, Wormald RP, Fletcher AE (2005) Cause-specific visual impairment and mortality: Results from a population-based study of older people in the United Kingdom. Arch Ophthalmol 123:1397-1403
9. Knudtson MD, Klein BE, Klein R (2006) Age-related eye disease, visual impairment, and survival: The Beaver Dam Eye Study. Arch Ophthalmol 124:243-249
10. Clemons TE, Kurinij N, Sperduto RD, AREDS Research Group (2004) Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Arch Ophthalmol 122:716-726
11. West SK, Munoz B, Rubin GS, Schein OD, Bandeen-Roche K, Zeger S, German S, Fried LP (1997) Function and visual impairment in a population-based study of older adults: The SEE project: Salisbury Eye Evaluation. Invest Ophthalmol Vis Sci 38:72-82
12. Lee P, Smith JP, Kington R (1999) The relationship of self-rated vision and hearing to functional status and well-being among seniors 70 years and older. Am J Ophthalmol 127:447-452
13. Horowitz A, Reinhardt JP, Boerner K (2005) The effect of rehabilitation on depression among visually disabled older adults. Aging Ment Health 9:563-570
14. Rumsfeld JS, Jones PG, Whooley MA, Sullivan MD, Pitt B, Weintraub WS, Spertus JA (2005) Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure. Am Heart J 150:961-967
15. Ramrattan RS, Wolfs RCW, Panda-Jonas S, Jonas JB, Bakker D, Pols HAP, Hofman A, de Jong PTVM (2001) Visual field loss in the elderly: prevalence, causes and associations with daily life functioning. The Rotterdam Study. Arch Ophthalmol 119:1788-1794